1. Home
  2. LBRDA vs BIO Comparison

LBRDA vs BIO Comparison

Compare LBRDA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBRDA
  • BIO
  • Stock Information
  • Founded
  • LBRDA 2014
  • BIO 1952
  • Country
  • LBRDA United States
  • BIO United States
  • Employees
  • LBRDA N/A
  • BIO N/A
  • Industry
  • LBRDA Cable & Other Pay Television Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • LBRDA Telecommunications
  • BIO Industrials
  • Exchange
  • LBRDA Nasdaq
  • BIO Nasdaq
  • Market Cap
  • LBRDA 10.8B
  • BIO 9.1B
  • IPO Year
  • LBRDA N/A
  • BIO N/A
  • Fundamental
  • Price
  • LBRDA $74.76
  • BIO $342.01
  • Analyst Decision
  • LBRDA Buy
  • BIO Strong Buy
  • Analyst Count
  • LBRDA 2
  • BIO 4
  • Target Price
  • LBRDA $83.50
  • BIO $414.00
  • AVG Volume (30 Days)
  • LBRDA 112.6K
  • BIO 158.1K
  • Earning Date
  • LBRDA 02-14-2025
  • BIO 02-13-2025
  • Dividend Yield
  • LBRDA N/A
  • BIO N/A
  • EPS Growth
  • LBRDA 20.89
  • BIO N/A
  • EPS
  • LBRDA 5.43
  • BIO N/A
  • Revenue
  • LBRDA $1,003,000,000.00
  • BIO $2,580,209,000.00
  • Revenue This Year
  • LBRDA $4.59
  • BIO N/A
  • Revenue Next Year
  • LBRDA $2.14
  • BIO $2.92
  • P/E Ratio
  • LBRDA $13.72
  • BIO N/A
  • Revenue Growth
  • LBRDA 2.24
  • BIO N/A
  • 52 Week Low
  • LBRDA $47.17
  • BIO $262.12
  • 52 Week High
  • LBRDA $100.44
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • LBRDA 41.14
  • BIO 53.78
  • Support Level
  • LBRDA $72.02
  • BIO $335.42
  • Resistance Level
  • LBRDA $77.97
  • BIO $351.96
  • Average True Range (ATR)
  • LBRDA 1.41
  • BIO 9.09
  • MACD
  • LBRDA 0.07
  • BIO 2.06
  • Stochastic Oscillator
  • LBRDA 46.05
  • BIO 59.23

About LBRDA Liberty Broadband Corporation

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: